Skip to main content

Closed

RGEN: Repligen Corporation Stock Analysis | finqOS

Healthcare · Medical - Instruments & Supplies

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth+0.3% / yr

Operating margin8.3%

ROIC1.8%

Financially safe

Adequate

Debt / equity0.33×

Interest coverage3.0×

Current ratio9.20×

Valuation

Unrated

P/E ratio190.6×

Repligen Corporation

RGENNASDAQ Global Select·USD·Closed

Repligen Corporation

RGENNASDAQ·USD·Closed

$141.01

−1.80%

$141.01

−$2.59 (1.80%)

52W Range

54thpctl

Volume

0.68×avg

Mkt Cap

7.96BUSD

P/E

190.6TTM

Div Yield

–ann

52W Range

54thpctl

Volume

0.68×avg

Market Cap

7.96BUSD

P/E Ratio

190.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings